Evidence map›Paper›PMID 29511073›Full record

ArticlemBio2018

Diagnosis of Zika Virus Infection by Peptide Array and Enzyme-Linked Immunosorbent Assay.

Nischay Mishra, Adrian Caciula, Adam Price, Riddhi Thakkar, James Ng, Lokendra V Chauhan, Komal Jain, Xiaoyu Che, Diego A Espinosa, Magelda Montoya Cruz and 12 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. A Systematic Review on Yellow Fever Vaccine and Adverse Events.Global health, epidemiology and genomics · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Frontiers in immunology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Nischay MishraCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA nm2641@cumc.columbia.edu wil2001@cumc.columbia.edu.
Adrian CaciulaCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Adam PriceCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Riddhi ThakkarCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
James NgCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Lokendra V ChauhanCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Komal JainCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Xiaoyu CheCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Diego A EspinosaDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.
Magelda Montoya CruzDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.
Angel BalmasedaLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Eric H SullivanRoche Madison, Madison, Wisconsin, USA.
Jigar J PatelRoche Madison, Madison, Wisconsin, USA.
Richard G JarmanViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Jennifer L RakemanPublic Health Laboratory, New York City Department of Health and Mental Hygiene, New York, New York, USA.
Christina T EganBiodefense Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Chantal B E M ReuskenWHO Collaborating Centre for Arbovirus and Viral Haemorrhagic Fever Reference and Research, Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Marion P G KoopmansWHO Collaborating Centre for Arbovirus and Viral Haemorrhagic Fever Reference and Research, Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.
Rafal TokarzCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Thomas BrieseCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
W Ian LipkinCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA nm2641@cumc.columbia.edu wil2001@cumc.columbia.edu.
Columbia University · USUniversity of California, Berkeley · USErasmus University Rotterdam · NLNational Autonomous University of Nicaragua · NINew York City Department of Health and Mental Hygiene · USWadsworth Center · USWalter Reed Army Institute of Research · US

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
T Cell Responses Following DENV Natural Infections and Live-Attenuated Dengue Virus VaccinationP01AI106695 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Eva Harris · 2015 to 2026
$34.1M
Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARIC, RALPH S · 2014 to 2018
$32.6M
Epidemiological, Clinical & Immunological Studies of Zika, dengue and chikungunyaR01AI099631 · NIAID · SUSTAINABLE SCIENCES INSTITUTE · PI BALMASEDA, ANGEL LAZARO · 2012 to 2021
$1.8M
NIAID NIH HHS P01 AI106695NIAID NIH HHS R01 AI099631NIAID NIH HHS U19 AI109761NIAID NIH HHS U19 AI118610
6 · The paper itself

Abstract

Zika virus (ZIKV) is implicated in fetal stillbirth, microcephaly, intracranial calcifications, and ocular anomalies following vertical transmission from infected mothers. In adults, infection may trigger autoimmune inflammatory polyneuropathy. Transmission most commonly follows the bite of infected

Indexed as

ArbovirusesCommunicable Diseases, EmergingEnzyme-Linked Immunosorbent AssayFlavivirusRNA, ViralZika VirusZika Virus InfectionRNA, Viralarbovirusemerging infectious diseasesflavivirusserologyZika

Identifiers

PMID29511073
PMCPMC5844993
OpenAlexW2789967317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.